Fund holders13F
Funds That Own Royalty Pharma plc (RPRX)
2 of the 26 major funds we track reported RPRX in their latest 13F, worth $120.9M combined at quarter end.
| Fund | Quarter | Shares | Value | Change |
|---|---|---|---|---|
| Renaissance Technologies | Q2 2026 | 1,935,800 | $108.5M | ▲ +144.7% |
| Bridgewater Associates | Q2 2026 | 219,687 | $12.3M | ▲ New |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
A 13F lists long positions in U.S.-listed stocks and some options at quarter end. It does not show short positions, cash, most foreign holdings, or trades made since. What a 13F can't tell you →